|
2026
|
P/S
|
Chemical, biological, analytical, and/or chromatographic
substances, active agents, and/or compo... |
|
|
P/S
|
Chemical, biological and analytical preparations, active agents, and/or compositions, in particul... |
|
|
P/S
|
Chemical, biological and analytical preparations, active
agents, and/or compositions, in particu... |
|
|
P/S
|
Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compos... |
|
|
Invention
|
Novel fusions proteins for extended half-life of vegf binding proteins. The present invention rel... |
|
|
Invention
|
Immunoglobulin binding proteins for affinity purification.
Immunoglobulin (Ig) binding proteins ... |
|
2025
|
Invention
|
Novel folr1 specific binding proteins for cancer diagnosis and treatment.
The present invention ... |
|
|
Invention
|
Novel dsrna binding ligands and their use in affinity chromatography. The present invention relat... |
|
|
Invention
|
Novel ligand for human tissue plasminogen activator. The present invention relates to novel affin... |
|
|
Invention
|
Specific binding proteins for human erb-b3 receptor tyrosine kinase 3 (her3). The present inventi... |
|
|
Invention
|
New ligands for the purification of antibodies via affinity chromatography. The present invention... |
|
|
Invention
|
Novel binding proteins for hyaluronic acid. The present invention relates to new hyaluronic acid ... |
|
2024
|
Invention
|
Novel serum albumin-binding fusion proteins |
|
|
Invention
|
Novel serum albumin-binding fusion proteins. The invention relates to fusion proteins that compri... |
|
2023
|
Invention
|
New ligands for affinity chromatography.
The present invention relates to novel ligands for affi... |
|
|
Invention
|
New ligands for affinity chromatography |
|
|
Invention
|
New ligands for affinity chromatography. The present invention relates to novel ligands for affin... |
|
|
Invention
|
Novel proteins with high binding affinity to programmed death ligand 1 (pd-l1).
The present inve... |
|
|
Invention
|
Novel proteins with high binding affinity to programmed death ligand 1 (pd-l1) |
|
|
Invention
|
Novel proteins with high binding affinity to programmed death ligand 1 (pd-l1). The present inven... |
|
|
Invention
|
Fusion proteins with half life extending domains.
The invention relates to a fusion protein that... |
|
|
Invention
|
Fusion proteins with half life extending domains. The invention relates to a fusion protein that ... |
|
|
P/S
|
Scientific, technological, and industrial research services all in the field of half-life modifyi... |
|
|
Invention
|
Immunoglobulin binding proteins for affinity purification. The present invention relates to immun... |
|
|
Invention
|
High affinity purification of ferritin.
The present invention relates to novel proteins that spe... |
|
|
Invention
|
High affinity purification of ferritin. The present invention relates to novel proteins that spec... |
|
2022
|
Invention
|
Specific binding molecules for fibroblast activation protein (fap).
The present invention relate... |
|
|
Invention
|
Specific binding molecules for fibroblast activation protein (fap). The present invention relates... |
|
|
Invention
|
Specific baculovirus major envelope glycoprotein gp64 binding proteins.
gp64 is the major envelo... |
|
|
Invention
|
Specific baculovirus major envelope glycoprotein gp64 binding proteins. gp64 is the major envelop... |
|
|
Invention
|
Affinity ligands for the purification and detection of ubiquitin muteins.
The present invention ... |
|
|
Invention
|
Affinity ligands for the purification and detection of ubiquitin muteins. The present invention r... |
|
|
P/S
|
Biological, diagnostic, therapeutic, biochemical substances, active agents, and/or compositions f... |
|
|
Invention
|
Novel human programmed death ligand 1 (pd-l1) specific binding molecules.
The present invention ... |
|
|
Invention
|
Novel human programmed death ligand 1 (pd-l1) specific binding molecules. The present invention r... |
|
2021
|
Invention
|
Binding proteins for complement factor h (cfh).
The present invention relates to novel proteins ... |
|
|
Invention
|
Binding protein for complement factor h (cfh). The present invention relates to novel proteins th... |
|
|
Invention
|
New type ii collagen binding proteins.
The present invention relates to new type II collagen alp... |
|
|
Invention
|
Novel type ii collagen binding proteins. The present invention relates to new type II collagen al... |
|
|
Invention
|
Fusion proteins with specifity for type ii collagen and vegf-a for the treatment of eye diseases.... |
|
|
Invention
|
Serum stable binding proteins for human her2 for theranostic applications.
The present disclosur... |
|
|
Invention
|
Serum stable binding proteins for human her2 for theranostic applications. The present disclosure... |
|
|
Invention
|
Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus ... |
|
|
Invention
|
Immunoglobulin binding polypeptides. The present invention relates to novel engineered artificial... |
|
|
Invention
|
Affinity ligand for the soluble part of fibroblast growth factor receptor 3 (sfgfr3).
The presen... |
|
2020
|
Invention
|
Binding proteins for the enzyme acid alpha glucosidase (gaa) and uses thereof. The present invent... |
|
|
Invention
|
Psma specific binding proteins for cancer diagnosis and treatment. Binding proteins that are spec... |
|
2019
|
Invention
|
Folr1 specific binding proteins for cancer diagnosis and treatment. The present invention relates... |
|
|
Invention
|
Triple-helical polypeptides lacking binding affinity for the fc domain of immunoglobulin and uses... |
|
|
P/S
|
Chemical, biological, analytical and/or chromatographic substances, active ingredients and/or com... |
|
2018
|
P/S
|
Diagnostic, therapeutic, analytical, biological, chemical,
biochemical substances, active agents... |
|
|
P/S
|
Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents,... |
|
|
P/S
|
Chemicals, biological, analytical, and/or chromatographic
preparations, active agents, and/or co... |
|
|
P/S
|
[ Chemicals, biological, analytical, and chromatographic preparations, active agents, and composi... |
|
|
P/S
|
Chemicals, biological, analytical, and/or chromatographic preparations, active agents, and/or com... |
|
|
P/S
|
Chemische, biologische, analytische, und/oder chromatographische Erzeugnisse, Wirkstoffe, und/ode... |
|
2012
|
P/S
|
Chemicals used in industry and science,In particular comprising antibody-like proteins or parts t... |
